BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
169 results:

  • 1. Activation of the pi3k/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
    Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
    Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
    Lin Y; Dong C; Zhang J; Zhu Y
    Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
    Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
    Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
lung cancer].
    Zhang Y; Wang Y; Liu M
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via pi3k/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With
    Ito S; Tsurumi K; Shindo N; Soma S; Yamaguchi K; Tamai K; Mochizuki M; Fujimori H; Morita M; Watanabe K; Suzuki A; Fukuhara T; Yasuda J
    Anticancer Res; 2023 Nov; 43(11):5031-5040. PubMed ID: 37909987
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via pi3k/Akt/mTOR and autophagy pathways.
    Xu H; Wang J; Al-Nusaif M; Ma H; Le W
    Cell Prolif; 2024 Mar; 57(3):e13560. PubMed ID: 37850256
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non-small cell lung cancer.
    Liu J; Li J; Tuo Z; Hu W; Liu J
    J Biol Chem; 2023 Nov; 299(11):105302. PubMed ID: 37777155
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
    Ying J; Hong H; Yu C; Jiang M; Ding D
    Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
    Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK lung Panel on the MassARRAY System in Metastatic Non-Small Cell lung cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives.
    Zhou WC; Zhang QF; Chen JL; Gan JP; Li YK; Zou J
    Clin Exp Med; 2023 Dec; 23(8):4449-4456. PubMed ID: 37659993
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gene-level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay.
    Jeon T; Oh UJ; Min J; Kim C
    Thorac Cancer; 2023 Sep; 14(26):2635-2641. PubMed ID: 37469197
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
    Smyth EN; John J; Tiu RV; Willard MD; Beyrer JK; Bowman L; Sheffield KM; Han Y; Brastianos PK
    Oncologist; 2023 Nov; 28(11):e1075-e1091. PubMed ID: 37358877
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis.
    Feng J; Xu B; Dai C; Wang Y; Xie G; Yang W; Zhang B; Li X; Wang J
    Oncol Res; 2021; 29(5):331-349. PubMed ID: 37305161
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. pi3k/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells.
    Navaei ZN; Khalili-Tanha G; Zangouei AS; Abbaszadegan MR; Moghbeli M
    Oncol Res; 2021; 29(4):235-250. PubMed ID: 37303943
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in lung cancer Patients for diagnosis and Therapy Monitoring.
    Ahmed M; Wuethrich A; Constantin N; Shanmugasundaram KB; Mainwaring P; Kulasinghe A; O'Leary C; O'Byrne K; Sina AA; Carrascosa LG; Trau M
    Anal Chem; 2023 Jun; 95(22):8522-8532. PubMed ID: 37224231
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A review on the role of HAND2-AS1 in cancer.
    Ghafouri-Fard S; Hussen BM; Abdullah SR; Dadyar M; Taheri M; Kiani A
    Clin Exp Med; 2023 Nov; 23(7):3179-3188. PubMed ID: 37204522
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.